Abstract: A system includes: a reception unit that receives print settings; a production unit that causes a production device to form an image on a three-dimensional medium and produce printed matter based on the print settings; and a test unit that performs a test in which the image is applied to the medium or a test medium corresponding to the medium based on the print settings before forming the image on the medium to make a user determine whether or not the print settings are appropriate.

Abstract: A printed matter production system includes an image acquiring section that acquires an image; a signature acquiring section that acquires a handwritten signature; a synthesizing section that synthesizes the signature and the image according to a synthesis method based on at least one of the image and the signature; and a printing section that prints the image after the synthesis so as to produce a printed matter.

Abstract: A printed material production system includes: a reception section configured to receive an order of a printed material; when the order includes production of the three-dimensional printed material, an output section configured to output a first preview indicating a plurality of faces of the three-dimensional printed material after printing; and a production section configured to print in accordance with the order to produce the three-dimensional printed material.

Abstract: Provided is a composition containing a polymer obtained by polymerizing a water-soluble unsaturated carboxylic acid monomer in the presence of a water-soluble sucrose allyl ether, with a low pH and a high viscosity. More specifically, provided is a composition containing (A) a polymer obtained by polymerizing a water-soluble unsaturated carboxylic acid monomer in the presence of a water-soluble sucrose allyl ether, (B) a polymer obtained by polymerizing at least acrylic acid and/or methacrylic acid in the presence of pentaerythritol allyl ether, wherein the amount of the pentaerythritol allyl ether is 0.1 parts by mass or more per 100 parts by mass of the acrylic acid and/or methacrylic acid, and water, the composition having a pH of 5.2 or lower and a viscosity of 1000 mPa·s or higher.

Abstract: A medicament having a higher therapeutic effect than that provided by administration of a recombinant antibody against human CC chemokine receptor 4 or an antibody fragment thereof or an agent alone is provided.